Gala­pa­gos CEO Paul Stof­fels bets €225M on a new CAR-T strat­e­gy for the long suf­fer­ing biotech

3 years ago
Deals

No­var­tis los­es patent ap­peal for block­buster MS drug, open­ing the door to gener­ic ri­vals

3 years ago
Pharma
Law

Flori­da man faces 100+ years in prison for al­leged­ly dis­trib­ut­ing $230M in adul­ter­at­ed drugs

3 years ago
Marketing

#Can­nes­Lions2022 Mar­ket­ingRx roundup: Li­ons health down­size gets mixed re­views; An­ti-obe­si­ty cam­paign wins Grand Prix

3 years ago
Pharma
Marketing

#Can­nes­Lions2022: P&G mar­ket­ing leg­end Marc Pritchard pitch­es cre­ativ­i­ty for growth — and good

3 years ago
Pharma
Marketing

'Put up or shut up': Biden, Dems have one last chance to res­ur­rect drug pric­ing re­forms ahead of elec­tions

3 years ago
Pharma

#Can­nes­Lions2022: Wal­greens buys in­to clin­i­cal tri­als as cre­ative team takes a new post-Covid tone

3 years ago
Pharma
Marketing

Cen­ter for Break­through Med­i­cines plans for an even larg­er dive in­to cell ther­a­py man­u­fac­tur­ing

3 years ago
Manufacturing

Eu­ro­pean Com­mis­sion opens in­ves­ti­ga­tion in­to Vi­for for po­ten­tial­ly dis­parag­ing a com­peti­tor

3 years ago
Pharma
Law

Big da­ta meets Big Phar­ma: Pfiz­er buys re­al-time pa­tient re­sults in col­lab­o­ra­tion with Tru­ve­ta

3 years ago
R&D

PTC of­fers its best case for a con­tro­ver­sial Duchenne MD PhI­II. But key fail­ures spark fresh doubts of suc­cess at FDA

3 years ago
R&D

PhI­II dead end for celi­ac drug crush­es pen­ny stock biotech

3 years ago
R&D

MIT lab cre­ates tool to find can­cer mu­ta­tion dri­vers 'any­where in the genome'

3 years ago
AI
Discovery

Hu­man Longevi­ty makes a move to­ward Nas­daq with po­ten­tial SPAC deal, but noth­ing's fi­nal yet

3 years ago
Financing

Rare dis­ease out­fit Ac­er fum­bles at FDA, re­ceiv­ing CRL due to lack of in­spec­tion readi­ness at pack­ag­ing man­u­fac­tur­er

3 years ago
FDA+

Medicare could save more than $3B an­nu­al­ly by us­ing Mark Cuban's new on­line gener­ic drug com­pa­ny — study

3 years ago
Pharma

#Can­nes­Lions2022: IPG Health nabs health­care net­work and ad agency hon­ors, while VM­LY&R cel­e­brates dou­ble Grand Prix ...

3 years ago
Pharma
Marketing

#Can­nes­Lions2022: 'Raise the bar': Bay­er con­sumer mar­ket­ing head looks to give phar­ma cre­ativ­i­ty a lit­tle push

3 years ago
Pharma
Marketing

Mer­ck touts new da­ta for break­through pneu­mo­coc­cal vac­cine as it heads to PhI­II tri­als

3 years ago
R&D
Pharma

15 lead­ers giv­ing voice and vis­i­bil­i­ty to the LGBTQ com­mu­ni­ty in bio­phar­ma

3 years ago
People
Special

Car­bon Bio­sciences emerges with a new vi­ral vec­tor to shake up the cys­tic fi­bro­sis gene ther­a­py field

3 years ago
Financing
Startups

Pfiz­er nabs $95M stake in Val­ne­va as Ly­me dis­ease vac­cine ap­proach­es piv­otal study

3 years ago
Financing
Deals

As­traZeneca says its $200M cash bet on Io­n­is’ AT­TR drug is pay­ing off — with PhI­II da­ta set­ting up FDA fil­ing

3 years ago
R&D

#Can­nes­Lions2022: J&J and Bay­er nab health and well­ness wins in tech-filled cat­e­go­ry

3 years ago
Pharma
Marketing
First page Previous page 510511512513514515516 Next page Last page
A service from the Financial Times